Certain Class B Ordinary Shares of Frazier Lifesciences Acquisition Corporation are subject to a Lock-Up Agreement Ending on 6-JUN-2021. These Class B Ordinary Shares will be under lockup for 180 days starting from 8-DEC-2020 to 6-JUN-2021.

Details:
The sponsor and the officers and directors have agreed that, for a period of 180 days from the date of the prospectus, they will not, without the prior written consent of Credit Suisse Securities (USA) LLC, offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any units, warrants, shares of common stock or any securities convertible into, or exercisable or exchangeable for, shares of common stock.